Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 200

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

The adverse health effects of cannabis use: What are they, and what are their implications for policy?

Hall, Wayne·2009·International Journal of Drug Policy

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drugpo.2009.02.013

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 115

  1. Aceto, 1996, Dependence studies on delta-9-tetrahydrocannabinol: Studies on precipitated and abrupt withdrawal, Journal of Pharmacology and Experimental Therapeutics, 278, 1290, 10.1016/S0022-3565(25)20781-9 · DOI · Paper page
  2. Adams, 1996, Cannabis: Pharmacology and toxicology in animals and humans, Addiction, 91, 1585, 10.1111/j.1360-0443.1996.tb02264.x · doi:10.1111/j.1360-0443.1996.tb02264.x · Paper page
  3. Ajdacic-Gross, 2007, Changing incidence of psychotic disorders among the young in Zurich, Schizophrenia Research, 95, 9, 10.1016/j.schres.2007.06.001 · DOI
  4. Aldington, 2008, Cannabis use and risk of lung cancer: A case–control study, European Respiratory Journal, 31, 280, 10.1183/09031936.00065707 · DOI · Paper page
  5. Aldington, 2007, Effects of cannabis on pulmonary structure, function and symptoms, Thorax, 62, 1058, 10.1136/thx.2006.077081 · DOI · Paper page
  6. Andreasson, 1987, Cannabis and schizophrenia: A longitudinal study of Swedish conscripts, Lancet, 2, 1483, 10.1016/S0140-6736(87)92620-1 · DOI · Paper page
  7. Aronow, 1974, Effect of marihuana and placebo marihuana smoking on angina pectoris, New England Journal of Medicine, 291, 65, 10.1056/NEJM197407112910203 · DOI · Paper page
  8. Aronow, 1975, Effect of smoking marijuana and of a high nicotine cigarette on angina pectoris, Clinical Pharmacology and Therapeutics, 17, 549, 10.1002/cpt1975175549 · DOI
  9. Arseneault, 2002, Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study, BMJ, 325, 1212, 10.1136/bmj.325.7374.1212 · DOI · Paper page
  10. Asbridge, 2005, Motor vehicle collision risk and driving under the influence of cannabis: Evidence from adolescents in Atlantic Canada, Accident Analysis and Prevention, 37, 1025, 10.1016/j.aap.2005.05.006 · DOI
  11. Bates, 1999, Role of cannabis in motor vehicle crashes, Epidemiologic Reviews, 21, 222, 10.1093/oxfordjournals.epirev.a017998 · DOI
  12. Boydell, 2006, Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999, Psychological Medicine, 36, 1441, 10.1017/S0033291706008440 · DOI · Paper page
  13. Budney, 2006, The cannabis withdrawal syndrome, Current Opinion in Psychiatry, 19, 233, 10.1097/01.yco.0000218592.00689.e5 · DOI · Paper page
  14. Budney, 2004, Review of the validity and significance of cannabis withdrawal syndrome, American Journal of Psychiatry, 161, 1967, 10.1176/appi.ajp.161.11.1967 · DOI · Paper page
  15. Cadoni, 2001, Behavioural sensitization after repeated exposure to [Delta]9-tetrahydrocannabinol and cross-sensitization with morphine, Psychopharmacology, 158, 259, 10.1007/s002130100875 · DOI · Paper page
  16. Caspi, 2005, Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction, Biological Psychiatry, 57, 1117, 10.1016/j.biopsych.2005.01.026 · DOI · Paper page
  17. Chait, 1992, Effects of smoked marijuana on human performance: A critical review, 387
  18. Coffey, 2003, Adolescent precursors of cannabis dependence: Findings from the Victorian Adolescent Health Cohort Study, British Journal of Psychiatry, 182, 330, 10.1192/bjp.182.4.330 · DOI
  19. Cohen, 1976, The 94-day cannabis study, Annals of the New York Academy of Sciences, 282, 110, 10.1111/j.1749-6632.1976.tb49900.x · doi:10.1111/j.1749-6632.1976.tb49900.x
  20. Compton, 1990, Cannabis dependence and tolerance production, Advances in Alcohol and Substance Abuse, 9, 129, 10.1300/J251v09n01_08 · DOI
  21. Cook, 1998, CB1 receptor antagonist precipitates withdrawal in mice exposed to delta9-tetrahydrocannabinol, Journal of Pharmacology and Experimental Therapeutics, 285, 1150, 10.1016/S0022-3565(24)37499-3 · DOI
  22. Copeland, 2001, Clinical profile of participants in a brief intervention program for cannabis use disorder, Journal of Substance Abuse Treatment, 20, 45, 10.1016/S0740-5472(00)00148-3 · DOI · Paper page
  23. D'Souza, 2007, Cannabinoids and psychosis, International Review of Neurobiology, 78, 289, 10.1016/S0074-7742(06)78010-2 · DOI
  24. Degenhardt, 2001, The association between psychosis and problematical drug use among Australian adults: Findings from the National Survey of Mental Health and Well-being, Psychological Medicine, 31, 659, 10.1017/S0033291701003865 · DOI · Paper page
  25. Degenhardt, 2003, Testing hypotheses about the relationship between cannabis use and psychosis, Drug and Alcohol Dependence, 71, 37, 10.1016/S0376-8716(03)00064-4 · DOI · Paper page
  26. Dennis, 2002, Changing the focus: The case for recognizing and treating cannabis use disorders, Addiction, 97, 4, 10.1046/j.1360-0443.97.s01.10.x · DOI · Paper page
  27. Donovan, 1983, Problem drinking and the dimension of involvement with drugs: A Guttman scalogram analysis of adolescent drug use, American Journal of Public Health, 73, 543, 10.2105/AJPH.73.5.543 · DOI · Paper page
  28. Donovan, 1985, Structure of problem behavior in adolescence and young adulthood, Journal of Consulting and Clinical Psychology, 53, 890, 10.1037/0022-006X.53.6.890 · doi:10.1037/0022-006x.53.6.890 · Paper page
  29. Duncan, 1998, Contributions of the social context to the development of adolescent substance use: A multivariate latent growth modeling approach, Drug and Alcohol Dependence, 50, 57, 10.1016/S0376-8716(98)00006-4 · DOI · Paper page
  30. Dutch National Alcohol and Drug Information System, 2004, Treatment demand of cannabis clients in outpatient addiction care in the Netherlands (1994–2001), LADIS Bulletin
  31. Ellickson, 1998, Does early drug use increase the risk of dropping out of high school?, Journal of Drug Issues, 28, 357, 10.1177/002204269802800205 · DOI
  32. ElSohly, 2000, Potency trends of delta(9)-THC and other cannabinoids in confiscated marijuana from 1980–1997, Journal of Forensic Sciences, 45, 24, 10.1520/JFS14636J · DOI · Paper page
  33. Fergusson, 2006, Cannabis use and other illicit drug use: Testing the cannabis gateway hypothesis, Addiction, 101, 556, 10.1111/j.1360-0443.2005.01322.x · DOI · Paper page
  34. Fergusson, 1997, Early onset cannabis use and psychosocial adjustment in young adults, Addiction, 92, 279, 10.1111/j.1360-0443.1997.tb03198.x · DOI · Paper page
  35. Fergusson, 1999, Prospective childhood predictors of deviant peer affiliations in adolescence, Journal of Child Psychology and Psychiatry and Allied Disciplines, 40, 581, 10.1111/1469-7610.00475 · doi:10.1111/1469-7610.00475 · Paper page
  36. Fergusson, 2000, Does cannabis use encourage other forms of illicit drug use?, Addiction, 95, 505, 10.1046/j.1360-0443.2000.9545053.x · DOI · Paper page
  37. Fergusson, 2002, Cannabis use and psychosocial adjustment in adolescence and young adulthood, Addiction, 97, 1123, 10.1046/j.1360-0443.2002.00103.x · DOI · Paper page
  38. Fergusson, 1996, The short-term consequences of early onset cannabis use, Journal of Abnormal Child Psychology, 24, 499, 10.1007/BF01441571 · DOI · Paper page
  39. Gable, 2004, Comparison of acute lethal toxicity of commonly abused psychoactive substances, Addiction, 99, 686, 10.1111/j.1360-0443.2004.00744.x · DOI · Paper page
  40. Gerberich, 2003, Marijuana use and injury events resulting in hospitalization, Annals of Epidemiology, 13, 230, 10.1016/S1047-2797(02)00411-8 · DOI
  41. Gottschalk, 1977, Effect of marijuana and placebo-marijuana smoking on psychological state and on psychophysiological and cardiovascular functioning in angina patients, Biological Psychiatry, 12, 255
  42. Grotenhermen, 2007, Developing limits for driving under cannabis, Addiction, 102, 1910, 10.1111/j.1360-0443.2007.02009.x · DOI · Paper page
  43. Hall, 1995, The public health significance of cannabis use in Australia, Australian Journal of Public Health, 19, 235, 10.1111/j.1753-6405.1995.tb00437.x · DOI
  44. Hall, 1997, The recent Australian debate about the prohibition on cannabis use, Addiction, 1109, 10.1111/j.1360-0443.1997.tb03668.x · doi:10.1111/j.1360-0443.1997.tb03668.x
  45. Hall, 2006, Cannabis use and the mental health of young people, Australian and New Zealand Journal of Psychiatry, 40, 105, 10.1080/j.1440-1614.2006.01756.x · DOI
  46. Hall, 2005, Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs, Drug and Alcohol Review, 24, 39, 10.1080/09595230500126698 · DOI · Paper page
  47. Hall, 2002, Cannabis use and cancer, Addiction, 97, 243, 10.1046/j.1360-0443.2002.00003.x · doi:10.1046/j.1360-0443.2002.00003.x
  48. Hall, 2000, The THC content of cannabis in Australia: Evidence and implications, Australian and New Zealand Journal of Public Health, 24, 503, 10.1111/j.1467-842X.2000.tb00500.x · DOI
  49. Hall, 1999, The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: Findings from the National Survey of Mental Health and Well-being, Addiction, 94, 1541, 10.1046/j.1360-0443.1999.9410154110.x · DOI · Paper page
  50. Han, 1999, Lifetime tobacco, alcohol and other substance use in adolescent Minnesota twins: Univariate and multivariate behavioral genetic analyses, Addiction, 94, 981, 10.1046/j.1360-0443.1999.9479814.x · DOI · Paper page
  51. Hashibe, 2005, Epidemiologic review of marijuana use and cancer risk, Alcohol, 35, 265, 10.1016/j.alcohol.2005.04.008 · DOI · Paper page
  52. Hashibe, 2006, Marijuana use and the risk of lung and upper aerodigestive tract cancers: Results of a population-based case–control study, Cancer Epidemiology, Biomarkers and Prevention, 15, 1829, 10.1158/1055-9965.EPI-06-0330 · DOI · Paper page
  53. Henningfield, 1998, Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association, Tobacco Control, 7, 281, 10.1136/tc.7.3.281 · DOI
  54. Henquet, 2004, Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people, BMJ, 330, 11, 10.1136/bmj.38267.664086.63 · DOI · Paper page
  55. Hickman, 2007, Cannabis and schizophrenia: Model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales, Addiction, 102, 597, 10.1111/j.1360-0443.2006.01710.x · DOI
  56. Hingson, 1982, Teenage driving after using marijuana or drinking and traffic accident involvement, Journal of Safety Research, 13, 33, 10.1016/0022-4375(82)90016-0 · DOI
  57. Hsairi, 1993, Etiologic factors in primary bronchial carcinoma in Tunisia [Facteurs etiologiques du cancer bronchique primitif en Tunisie], Tunisie Medicale, 71, 265
  58. Jones, 2002, Cardiovascular system effects of marijuana, Journal of Clinical Pharmacology, 42, 58S, 10.1002/j.1552-4604.2002.tb06004.x · DOI · Paper page
  59. Jones, 1976, The 30-day trip: Clinical studies of cannabis use, tolerance and dependence, Vol. 2, 627
  60. Kalant, 2004, Adverse effects of cannabis on health: An update of the literature since 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 28, 849, 10.1016/j.pnpbp.2004.05.027 · DOI · Paper page
  61. Kandel, 1984, Marijuana users in young adulthood, Archives of General Psychiatry, 41, 200, 10.1001/archpsyc.1984.01790130096013 · DOI · Paper page
  62. Kandel, 1988, Issues of sequencing of adolescent drug use and other problem behaviors, Drugs and Society, 3, 55
  63. Kandel, 1986, The consequences in young adulthood of adolescent drug involvement: An overview, Archives of General Psychiatry, 43, 746, 10.1001/archpsyc.1986.01800080032005 · DOI · Paper page
  64. Kelly, 2004, A review of drug use and driving: Epidemiology, impairment, risk factors and risk perceptions, Drug and Alcohol Review, 23, 319, 10.1080/09595230412331289482 · DOI · Paper page
  65. Kessler, 1994, Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey, Archives of General Psychiatry, 51, 8, 10.1001/archpsyc.1994.03950010008002 · DOI · Paper page
  66. Kleiman, 1992, Neither prohibition nor legalization: Grudging toleration in drug control policy, Daedalus, 121, 53
  67. Kouri, 2000, Abstinence symptoms during withdrawal from chronic marijuana use, Experimental and Clinical Psychopharmacology, 8, 483, 10.1037/1064-1297.8.4.483 · doi:10.1037/1064-1297.8.4.483 · Paper page
  68. Krohn, 1997, The interrelationship between substance use and precocious transitions to adult statuses, Journal of Health and Social Behavior, 38, 87, 10.2307/2955363 · DOI · Paper page
  69. Lamarque, 2001, Chronic treatment with [Delta] 9-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin: Implications for vulnerability to drug addiction, Neuropharmacology, 41, 118, 10.1016/S0028-3908(01)00039-9 · DOI
  70. Laumon, 2005, Cannabis intoxication and fatal road crashes in France: Population based case–control study, BMJ, 331, 1371, 10.1136/bmj.38648.617986.1F · DOI · Paper page
  71. Ledent, 1999, Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice, Science, 283, 401, 10.1126/science.283.5400.401 · DOI · Paper page
  72. Lichtman, 2001, Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine, Pharmacology, Biochemistry and Behavior, 69, 181, 10.1016/S0091-3057(01)00514-7 · DOI
  73. Lichtman, 1998, Effects of SR 141716A after acute or chronic cannabinoid administration in dogs, European Journal of Pharmacology, 357, 139, 10.1016/S0014-2999(98)00558-5 · DOI
  74. Lifrak, 1997, Relationship of perceived competencies, perceived social support, and gender to substance use in young adolescents, Journal of the American Academy of Child and Adolescent Psychiatry, 36, 933, 10.1097/00004583-199707000-00015 · DOI
  75. Llewellyn, 2004, An analysis of risk factors for oral cancer in young people: A case–control study, Oral Oncology, 40, 304, 10.1016/j.oraloncology.2003.08.015 · DOI · Paper page
  76. Lynskey, 2002, An alternative model is feasible, but the gateway hypothesis has not been invalidated: Comments on Morral et al., Addiction, 97, 1505, 10.1046/j.1360-0443.2002.00288.x · DOI
  77. Lynskey, 2000, The effects of adolescent cannabis use on educational attainment: A review, Addiction, 96, 433
  78. Lynskey, 2003, Escalation of drug use in early-onset cannabis users vs. co-twin controls, Jama—Journal of the American Medical Association, 289, 427, 10.1001/jama.289.4.427 · DOI · Paper page
  79. Lynskey, 1999, Prevalence of illicit drug use among youth: Results from the Australian school students’ alcohol and drugs survey, Australian and New Zealand Journal of Public Health, 23, 519, 10.1111/j.1467-842X.1999.tb01309.x · DOI
  80. MacPhee, 1999, Effects of marijuana on cell nuclei: A review of the literature relating to the genotoxicity of cannabis, 435
  81. Maldonado, 2002, Study of cannabinoid dependence in animals, Pharmacology and Therapeutics, 95, 153, 10.1016/S0163-7258(02)00254-1 · DOI
  82. Mannisto, 2006, Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors, Pharmacological Reviews, 51, 593, 10.1016/S0031-6997(24)01423-6 · DOI · Paper page
  83. Manzanares, 1999, Pharmacological and biochemical interactions between opioids and cannabinoids, Trends in Pharmacological Sciences, 20, 287, 10.1016/S0165-6147(99)01339-5 · DOI · Paper page
  84. Marselos, 1999, Mutagenicity, developmental toxicity and carcinogeneity of cannabis, Addiction Biology, 4, 5, 10.1080/13556219971786 · DOI
  85. McGee, 1993, Cannabis use among New Zealand adolescents, New Zealand Medical Journal, 106, 345
  86. McLaren, 2008, Cannabis potency and contamination: A review of the literature, Addiction, 103, 1100, 10.1111/j.1360-0443.2008.02230.x · DOI · Paper page
  87. Mehra, 2006, The association between marijuana smoking and lung cancer: A systematic review, Archives of Internal Medicine, 166, 1359, 10.1001/archinte.166.13.1359 · DOI · Paper page
  88. Mittleman, 2001, Triggering myocardial infarction by marijuana, Circulation, 103, 2805, 10.1161/01.CIR.103.23.2805 · DOI · Paper page
  89. Moir, 2008, A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions, Chemical Research in Toxicology, 21, 494, 10.1021/tx700275p · DOI · Paper page
  90. Morral, 2002, Reassessing the marijuana gateway effect, Addiction, 97, 1493, 10.1046/j.1360-0443.2002.00280.x · DOI · Paper page
  91. Murray, 2007, Cannabis, the mind and society: The hash realities, Nature Reviews Neuroscience, 8, 885, 10.1038/nrn2253 · DOI · Paper page
  92. Osgood, 1988, The generality of deviance in late adolescence and early adulthood, American Sociological Review, 53, 81, 10.2307/2095734 · DOI · Paper page
  93. Pijlman, 2005, Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops, Addiction Biology, 10, 171, 10.1080/13556210500123217 · DOI · Paper page
  94. Ramaekers, 2004, Dose related risk of motor vehicle crashes after cannabis use, Drug and Alcohol Dependence, 73, 109, 10.1016/j.drugalcdep.2003.10.008 · DOI · Paper page
  95. Resnick, 1997, Protecting adolescents from harm: Findings from the National Longitudinal Study on Adolescent Health, Jama—Journal of the American Medical Association, 278, 823, 10.1001/jama.278.10.823 · DOI · Paper page
  96. Rosenblatt, 2004, Marijuana use and risk of oral squamous cell carcinoma, Cancer Research, 64, 4049, 10.1158/0008-5472.CAN-03-3425 · DOI
  97. Sidney, 2002, Cardiovascular consequences of marijuana use, Journal of Clinical Pharmacology, 42, 64S, 10.1002/j.1552-4604.2002.tb06005.x · DOI · Paper page
  98. Sidney, 1997, Marijuana use and cancer incidence (California, United States), Cancer Causes and Control, 8, 722, 10.1023/A:1018427320658 · DOI
  99. Smart, 1976, Drug use and driving among high school students, Accident Analysis and Prevention, 8, 33, 10.1016/0001-4575(76)90031-2 · doi:10.1016/0001-4575(76)90031-2
  100. Stefanis, 2004, Early adolescent cannabis exposure and positive and negative dimensions of psychosis, Addiction, 99, 1333, 10.1111/j.1360-0443.2004.00806.x · DOI · Paper page
  101. Stephens, 1994, Treating adult marijuana dependence—a test of the relapse prevention model, Journal of Consulting and Clinical Psychology, 62, 92, 10.1037/0022-006X.62.1.92 · DOI · Paper page
  102. Swift, 1998, Characteristics of long-term cannabis users in Sydney, Australia, European Addiction Research, 4, 190, 10.1159/000018952 · DOI
  103. Swift, 2001, Cannabis use and dependence among Australian adults: Results from the National Survey of Mental Health and Well-being, Addiction, 96, 737, 10.1046/j.1360-0443.2001.9657379.x · DOI
  104. Tanda, 1997, Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism, Science, 276, 2048, 10.1126/science.276.5321.2048 · DOI · Paper page
  105. Tanner, 1999, Whatever happened to yesterday's rebels? Longitudinal effects of youth delinquency on education and employment, Social Problems, 46, 250, 10.1525/sp.1999.46.2.03x0188f · DOI
  106. Tashkin, 2001, Airway effects of marijuana, cocaine, and other inhaled illicit agents, Current Opinion in Pulmonary Medicine, 7, 43, 10.1097/00063198-200103000-00001 · DOI
  107. Tashkin, 2002, Respiratory and immunologic consequences of marijuana smoking, Journal of Clinical Pharmacology, 42, 71S, 10.1002/j.1552-4604.2002.tb06006.x · DOI · Paper page
  108. Taylor, 2002, A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults, Addiction, 97, 1055, 10.1046/j.1360-0443.2002.00169.x · DOI · Paper page
  109. Taylor, 2000, The respiratory effects of cannabis dependence in young adults, Addiction, 95, 1669, 10.1046/j.1360-0443.2000.951116697.x · DOI · Paper page
  110. Thomas, 1996, A community survey of adverse effects of cannabis use, Drug and Alcohol Dependence, 42, 201, 10.1016/S0376-8716(96)01277-X · DOI · Paper page
  111. True, 1999, Interrelationship of genetic and environmental influences on conduct disorder and alcohol and marijuana dependence symptoms, American Journal of Medical Genetics, 88, 391, 10.1002/(SICI)1096-8628(19990820)88:4<391::AID-AJMG17>3.0.CO;2-L · DOI
  112. Tsou, 1995, Physical withdrawal in rats tolerant to delta-9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist, European Journal of Pharmacology, 280, R13, 10.1016/0014-2999(95)00360-W · DOI · Paper page
  113. van Os, 2002, Cannabis use and psychosis: A longitudinal population-based study, American Journal of Epidemiology, 156, 319, 10.1093/aje/kwf043 · DOI · Paper page
  114. Wiesbeck, 1996, An evaluation of the history of a marijuana withdrawal syndrome in a large population, Addiction, 91, 1469, 10.1111/j.1360-0443.1996.tb02251.x · doi:10.1111/j.1360-0443.1996.tb02251.x
  115. Zhang, 1999, Marijuana use and increased risk of squamous cell carcinoma of the head and neck, Cancer Epidemiology Biomarkers and Prevention, 8, 1071

Cited by

See all 200

Metadata

Authors
Hall, W.
Venue
International Journal of Drug Policy
Publisher
Elsevier BV
Published
2009-11
Volume
20
Issue
6
Pages
458-466
ISSN
0955-3959 (ISSN-L)
OpenAlex
W2162530494
Cited by
200
References
14
FWCI
6.19
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The adverse health effects of cannabis use: What are they, and what are their implications for policy? https://app.cochat.ai/papers/10.1016/j.drugpo.2009.02.013
The paper
Hall, W. (2009). The adverse health effects of cannabis use: What are they, and what are their implications for policy? International Journal of Drug Policy. https://doi.org/10.1016/j.drugpo.2009.02.013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.